Si NASCE TUTTI PAZZI,MA QUALCUNO CI RESTA...... (2 lettori)

[Pitagora]

bravo qui so diventati tutti taccagni

...hai ragione....abbondiamo...senza mezze misure.

 

[PILU]

ragazzi ricordiamoci che il 30 giugno scade il pct ad un anno di oltre 400 mld offerto dalla bce all'1 % ... sicuramente li restituiranno vero ?

 

[frengo67]

...hai ragione....abbondiamo...senza mezze misure.

 

[olly®]

...hai ragione....abbondiamo

....e comprale stè tit!!!

 

[PILU]

Pfizer: utile in calo del 26% nel primo trimestre
di ANSA
Pesa la riforma sanitaria voluta da Barack Obama

(ANSA) - ROMA, 4 MAG - Utile in calo del 26% per Pfizer nel primo trimestre dell'anno sotto il peso della riforma sanitaria voluta dal Presidente Usa Barack Obama. Il gigante farmaceutico ha chiuso i primi tre mesi del 2010 con un utile di 2,03 miliardi di dollari, pari a 25 centesimi per azione, da 2,73 miliardi di dollari, pari a 40 centesimi per azione, segnati nello stesso periodo dell'anno scorso. Pfizer comunica che con la riforma sanitaria le vendite nel primo trimestre sono calate di 56 milioni di dollari.

non si comprano più le pillole blu ....

 

[gasto]

?

 

[gasto]

OLLY sbatte e risbatte sui 55 G.

ci hanno fatto a pezzi Landi però... Mediomerda perchè ci voglion salire non per altro..

 

[silpla2000]

il carrello della spesa stà cominciando ad essere costoso....d

stai a fa la raccolta differenziatad:d

 

[silpla2000]

Pfizer: utile in calo del 26% nel primo trimestre
di ANSA
Pesa la riforma sanitaria voluta da Barack Obama

(ANSA) - ROMA, 4 MAG - Utile in calo del 26% per Pfizer nel primo trimestre dell'anno sotto il peso della riforma sanitaria voluta dal Presidente Usa Barack Obama. Il gigante farmaceutico ha chiuso i primi tre mesi del 2010 con un utile di 2,03 miliardi di dollari, pari a 25 centesimi per azione, da 2,73 miliardi di dollari, pari a 40 centesimi per azione, segnati nello stesso periodo dell'anno scorso. Pfizer comunica che con la riforma sanitaria le vendite nel primo trimestre sono calate di 56 milioni di dollari.

non si comprano più le pillole blu ....

azz pure il viagra non tira più

 

[unlui]

Pfizer: utile in calo del 26% nel primo trimestre
di ANSA
Pesa la riforma sanitaria voluta da Barack Obama

(ANSA) - ROMA, 4 MAG - Utile in calo del 26% per Pfizer nel primo trimestre dell'anno sotto il peso della riforma sanitaria voluta dal Presidente Usa Barack Obama. Il gigante farmaceutico ha chiuso i primi tre mesi del 2010 con un utile di 2,03 miliardi di dollari, pari a 25 centesimi per azione, da 2,73 miliardi di dollari, pari a 40 centesimi per azione, segnati nello stesso periodo dell'anno scorso. Pfizer comunica che con la riforma sanitaria le vendite nel primo trimestre sono calate di 56 milioni di dollari.

non si comprano più le pillole blu ....

il viagra ci salvera'
abbassano i prezzi e si torna a trombare

ew York, May 4th (TradersHuddle.com) – Stock futures fell after China manufacturing dropped and European [COLOR=green ! important][COLOR=green ! important]debt[/COLOR][/COLOR] fears returned to center stage. The Dollar strengthened against the euro amid renewed worries that Greece is only the beginning of a much bigger crisis.
The euro hit a 12-month low against the greenback as fears grew that Greece's [COLOR=green ! important][COLOR=green ! important]debt [COLOR=green ! important]problems[/COLOR][/COLOR][/COLOR] would spread to other countries. Despite yesterday’s bailout, significant obstacles remained as Greece needs to implement drastic and non-popular spending cuts, which are spurring labor unrest in the country.

Early earnings news helped give the market some support. Dow components Merck and Pfizer beat profit estimates.

On economic news, at 10 am, March pending home sales and factory orders, will be released.

Stocks to watch: Alcoa (NYSE:AA), Bank of America (NYSEAC), Nike (NYSE:NKE), LeapFrog Enterprises (NYSE:LF), Pfizer (NYSEFE), Scotts Miracle-Gro (NYSEMG), and Stryker (NYSEYK),

Alcoa (NYSE:AA), the aluminum producer and Dow Component, was trading lower in early premarket trading, after metal prices plunged on reports that China manufacturing fell to a 6 month low, spurring concern that the demand for raw materials will slow at the fastest growing economy in the world.

Bank of America (NYSEAC), the largest U.S. lender, was trading 1.4% lower in early pre-market trading. The financial sector will be in focus as the Senate begins the final debate of the financial regulatory reform, with Paul Volcker, President Obama economic advisor, expressing that he feels confident that his now famous Volcker rule, limiting proprietary trading at financial institutions, will likely be part of the final financial regulatory reform bill.

Nike (NYSE:NKE), athletic footwear and apparel giant, might see a boost in tody’s trading session after TV host Jim Cramer recommended the stock in his Mad Money program. Cramer normally advise his viewers to wait some days to buy his recommendations, but this time he wanted for them to go and buy Nike ahead of its investor day on Wednesday. Cramer said that according to Goldman Sachs research, the stock tends to add 1% on the day of its meetings and then another 3% in the two weeks afterwards. Cramer called these investor days “hugely bullish affairs.” Jim said that at the conference, Nike would be able to talk of its strong earnings, growing gross margins, lean inventories, and futures orders. Additionally Nike may also talk about its booming international business, especially its China expansion plans, as well as next month’s World Cup.

Shares of LeapFrog (NYSE:LF), the maker of electronic children books and games, will certainly be under pressure in today’s trading session after the company posted a wider than expected first quarter loss. Shares of LeapFrog tumbled 10.1% in early pre-market trading.

Pfizer (NYSEFE), the maker of Viagra and Lipitor, will likely see some upside in today’s trading as the company reported better than expected first quarter earnings and revenues. Pfizer beat by $0.07 a share and issued in-line guidance. Investors will likely bid the pharma sector higher as they will likely play defense and move to defensive names. Yesterday in the [COLOR=green ! important][COLOR=green ! important]Fast [COLOR=green ! important]Money[/COLOR][/COLOR][/COLOR] program, the traders liked the stock and stated that money manager under own, giving Pfizer the potential for more upside.

Scotts Miracle-Gro (NYSEMG), the lawn and garden products and services provider, was downgraded by Jefferies to “Hold” from “Buy”. With the recent increases in input cost inflation, limited pricing flexibility, and operations primarily in the US, which has an already strained consumer. The company will potentially see a margin squeeze, affecting the overall earnings potential for the company going forward.

Stryker (NYSEYK), surgical devices and medical implants maker, might see some upside in today’s trading session after Bernstein upgraded the stock to “Outperform” from “Market Perform”.